Advanced search
Publication Cover
Current Medical Research and Opinion Volume 21, 2005 - Issue 8
Submit an article Journal homepage
1,701
Views
152
CrossRef citations to date
0
Altmetric
Original Article

Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period

Roger Bullock Kingshill Research Centre, Swindon, UKCorrespondence[email protected]
,
Jacques Touchon CHU Hôpital Guy de Chauliac, Montpellier, France
,
Howard Bergman McGill University, Montreal, Quebec, Canada
,
Giuseppe Gambina Ospedale Civile Maggiore, Verona, Italy
,
Yunsheng He Novartis Pharmaceuticals, East Hanover, NJ, USA
,
Günter Rapatz Novartis Pharma AG, Basel, Switzerland
,
Jennifer Nagel Novartis Pharma AG, Basel, Switzerland
&
Roger Lane Novartis Pharmaceuticals, East Hanover, NJ, USA
 show all
Pages 1317-1327 | Accepted 04 Jul 2005, Published online: 25 Jul 2005

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.